Compare MIST & CEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIST | CEPS |
|---|---|---|
| Founded | 2003 | 2021 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 147.9M |
| IPO Year | 2019 | N/A |
| Metric | MIST | CEPS |
|---|---|---|
| Price | $1.52 | $10.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 15.9K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,915.14 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $10.07 |
| 52 Week High | $3.06 | $10.18 |
| Indicator | MIST | CEPS |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 44.30 |
| Support Level | $1.38 | $10.10 |
| Resistance Level | $2.01 | $10.13 |
| Average True Range (ATR) | 0.14 | 0.02 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 65.19 | 50.00 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Cantor Equity Partners VI Inc is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.